Structured measures of sleep disturbance have not been systematically applied to SYNGAP1-ID nor has there been a comparison of sleep abnormalities between patients with synaptopathies such as SYNGAP1-related ID and PMD. This evidence concerns the gene SYNGAP1 and Pelizeaus-Merzbacher spectrum disorder.